Key Findings:  This study of children with autism spectrum disorder, (ASD) who were given gluten-casein or a placebo found that did not correlate to worsening gastrointestinal symptoms or maladaptive behaviors, and there was no difference in the urinary levels of intestinal fatty acids binding protein (I-FABP).
Type of Study:  Double Blind Clinical Trial
Study Sample Size:  74
Study Result:  Inconclusive
Study Location(s):  Belgium, Indonesia
Year of Pub:  2014
Cannabinoids Studied:  Fatty Acid-Binding Protein (FABP)
Phytocannabinoid Source:  Not Applicable